Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Qiagen N.V.    QGEN   NL0012169213

QIAGEN N.V.

(QGEN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryAll NewsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

share with twitter share with LinkedIn share with facebook
08/03/2020 | 04:10pm EDT

DGAP Voting Rights Announcement: QIAGEN N.V.
QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

03.08.2020 / 22:00
Dissemination of a Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


The AFM (the Netherlands Authority For the Financial Markets has informed us on August 1, 2020 that a notification related to our institution has been released by the AFM.

The following notification has been disclosed in the relevant register on the AFM website:

Date of transaction: 30 jul 2020
Person obliged to notify: Citigroup Inc.
Issuing institution: Qiagen N.V.
Registration Chamber of Commerce: 12036979
Place of residence: VENLO

Distribution in numbers

Type of share Number of shares Number of voting rights Capital interest Voting rights Manner of disposal Settlement
Swap 84.097,00 84.097,00 Potential Potential Indirectly - (Citigroup Global Markets Limited) In cash
Warrant 2,00 2,00 Potential Potential Indirectly - (Citigroup Global Markets Limited) In cash
Call Option 1.000,00 100.000,00 Potential Potential Indirectly - (Citigroup Global Markets Limited) Physical Delivery
Ordinary share 10.917.611,00 10.917.611,00 Real Real Indirectly - (Citigroup Global Markets Limited) Physical Delivery
 




Distribution in percentages

Type Total holding Directly real Directly potential Indirectly real Indirectly potential
Capital interest 4,81% 0,00% 0,00% 4,73% 0,08%
Voting rights 4,81% 0,00% 0,00% 4,73% 0,08%
 

QIAGEN N.V. is not responsible for the accuracy and correctness of the notification above. The content has been taken from the relevant register of the AFM:
https://www.afm.nl/en/professionals/registers/meldingenregisters/substantiele-deelnemingen/details?id=96602



03.08.2020 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: QIAGEN N.V.
Hulsterweg 82
5912 PL Venlo
Netherlands
Internet: www.qiagen.com

 
End of News DGAP News Service

1108361  03.08.2020 

fncls.ssp?fn=show_t_gif&application_id=1108361&application_name=news&site_id=zonebourse

© EQS 2020
share with twitter share with LinkedIn share with facebook
All news about QIAGEN N.V.
09/18QIAGEN NV : Warburg Research reiterates its Neutral rating
MD
09/17QIAGEN N : fully acquires NeuMoDx Molecular, Inc., rounding out portfolio of PCR..
BU
09/15QIAGEN NV : DZ Bank reiterates its Neutral rating
MD
09/14QIAGEN N.V. : Notification and public disclosure of transactions by persons
EQ
09/14QIAGEN N.V. : Notification and public disclosure of transactions by persons
EQ
09/14QIAGEN N.V. : Notification and public disclosure of transactions by persons
EQ
09/11QIAGEN NV : Deutsche Bank remains its Buy rating
MD
09/09QIAGEN NV : Kepler Cheuvreux reiterates its Neutral rating
MD
09/08QIAGEN : to Launch Rapid Portable Test That Can Analyze Over 30 Samples Per Hour..
BU
08/27QIAGEN N.V. : Notification and public disclosure of transactions by persons
EQ
More news
Financials (USD)
Sales 2020 1 799 M - -
Net income 2020 331 M - -
Net Debt 2020 991 M - -
P/E ratio 2020 36,8x
Yield 2020 -
Capitalization 11 783 M 11 783 M -
EV / Sales 2020 7,10x
EV / Sales 2021 6,12x
Nbr of Employees 5 200
Free-Float 92,9%
Chart QIAGEN N.V.
Duration : Period :
Qiagen N.V. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends QIAGEN N.V.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 13
Average target price 56,00 $
Last Close Price 51,51 $
Spread / Highest target 28,1%
Spread / Average Target 8,72%
Spread / Lowest Target -26,2%
EPS Revisions
Managers
NameTitle
Thierry Bernard Chief Executive Officer
Lawrence A. Rosen Chairman-Supervisory Board
Barthold Piening Senior Vice President & Head-Global Operations
Roland Sackers Chief Financial Officer & Managing Director
Metin Colpan Independent Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
QIAGEN N.V.52.40%11 783
LONZA GROUP AG60.36%45 446
SEATTLE GENETICS, INC.66.73%33 148
IQVIA HOLDINGS INC.0.52%29 706
CELLTRION, INC.42.27%29 181
MODERNA, INC.260.69%27 838